Intraorbital injection of triamcinolone acetonide in patients with idiopathic orbital inflammation

Archives of Ophthalmology

Volumn 125, Issue 12, 2007, Pages 1647-1651

  Leibovitch, Igal ^a   Prabhakaran, Venkatesh C ^b   Davis, Garry ^b   Selva, Dinesh ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; DIABETES MELLITUS; EYE EXAMINATION; EYE FUNDUS; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; NAUSEA AND VOMITING; ORBIT; PRIORITY JOURNAL; SIDE EFFECT; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLUCOCORTICOIDS; GRANULOMA, PLASMA CELL, ORBITAL; HUMANS; INJECTIONS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORBIT; PILOT PROJECTS; PROSPECTIVE STUDIES; RETREATMENT; TOMOGRAPHY, X-RAY COMPUTED; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY;

EID: 37149012481     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.12.1647     Document Type: Article

References (32)

1. Yuen SJ, Rubin PA. Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome. Arch Ophthalmol. 2003;121(4):491-499.
2. Hsuan JD, Selva D, McNab AA, Sullivan TJ, Saeed P, O'Donnell BA. Idiopathic sclerosing orbital inflammation. Arch Ophthalmol. 2006;124(9):1244-1250.
3. Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Idiopathic granulomatous orbital inflammation. Ophthalmology. 1996;103(12):2135- 2141.
4. Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 1996;103(3):521-528.
5. Ebner R, Devoto MH, Weil D, et al. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol. 2004;88(11):1380-1386.
6. Elner VM, Mintz R, Demirci H, Hassan AS. Local corticosteroid treatment of eyelid and orbital xanthogranuloma. Ophthal Plast Reconstr Surg. 2006;22(1):36-40.
7. Goldberg RA. Orbital steroid injections. Br J Ophthalmol. 2004;88(11):1359-1360.
8. Mohammad Ael-N. Intralesional steroid injection for management of acute idiopathic dacryoadenitis: a preliminary result. Ophthal Plast Reconstr Surg. 2005;21(2):138-141.
9. Kushner BJ. Intralesional corticosteroid injection for infantile adnexal hemangioma. Am J Ophthalmol. 1982;93(4):496-506.
10. Pizzarello LD, Jakobiec FA, Hofeldt AJ, Podolsky MM, Silvers DN. Intralesional corticosteroid therapy of chalazia. Am J Ophthalmol. 1978;85(6):818-821.
11. Bersani TA, Nichols CW. Intralesional triamcinolone for cutaneous palpebral sarcoidosis. Am J Ophthalmol. 1985;99(5):561-562.
12. Holsclaw DS, Whitcher JP, Wong IG, Margolis TP. Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis. Am J Ophthalmol. 1996;121(3):243-249.
13. Wasserman BN, Medow NB, Homa-Palladino M, Hoehn ME. Treatment of periocular capillary hemangiomas. J AAPOS. 2004;8(2):175-181.
14. Neumann D, Isenberg SJ, Rosenbaum AL, Goldberg RA, Jotterand VH. Ultrasonographically guided injection of corticosteroids for the treatment of retroseptal capillary hemangioma in infants. J AAPOS. 1997;1(1):34-40.
15. Garber MI. Methylprednisolone in the treatment of exophthalmos. Lancet. 1966;1(7444):958-960.
16. Thomas ID, Hart JK. Retrobulbar repository corticosteroid therapy in thyroid ophthalmopathy. Med J Aust. 1974;2(13):484-487.
17. Harris GJ. Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS Foundation Lecture. Ophthal Plast Reconstr Surg. 2006;22(2):79-86.
18. Ferrante P, Ramsey A, Bunce C, Lightman S. Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Experiment Ophthalmol. 2004;32:563-568.
19. Kalina PH, Erie JC, Rosenbaum L. Biochemical quantification of triamcinolone in subconjunctival depots. Arch Ophthalmol. 1995;113(7):867-869.
20. Herschler J. Intractable intraocular hypertension induced by repository triamcinolone acetonide. Am J Ophthalmol. 1972;74(3):501-504.
21. Lafranco Dafflon M, Tran VT, Guex-Crosier Y, Herbort CP. Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol. 1999;237(4):289-295.
22. Giles CL. Bulbar perforation during periocular injection of corticosteroids. Am J Ophthalmol. 1974;77(4):438-441.
23. Fogla R, Rao SK, Biswas J. Avoiding conjunctival necrosis after periocular depot corticosteroid injection. J Cataract Refract Surg. 2000;26(2):163-164.
24. Ellis PP. Occlusion of the central retinal artery after retrobulbar corticosteroid injection. Am J Ophthalmol. 1978;85(3):352-356.
25. Shorr N, Seiff SR. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg. 1986;17(4):229-231.
26. Gupta OP, Boynton JR, Sabini P, Markowitch W Jr, Quatela VC. Proptosis after retrobulbar corticosteroid injections. Ophthalmology. 2003;110(2):443-447.
27. Nozik RA. Orbital rim fat atrophy after repository periocular corticosteroid injection. Am J Ophthalmol. 1976;82(6):928-930.
28. Smith JR, George RK, Rosenbaum JT. Lower eyelid herniation of orbital fat may complicate periocular corticosteroid injection. Am J Ophthalmol. 2002;133 (6):845-847.
29. Dekhuijzen PN, Gayan-Ramirez G, de Bock V, Dom R, Decramer M. Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently. J Clin Invest. 1993;92(3):1534-1542.
30. Kushner BJ. Hemangiomas. Arch Ophthalmol. 2000;118(6):835-836.
31. Weiss AH. Adrenal suppression after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol. 1989;107(5):518-522.
32. Egbert JE, Paul S, Engel WK, Summers CG. High injection pressure during intralesional injection of corticosteroids into capillary hemangiomas. Arch Ophthalmol. 2001;119(5):677-683.